These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15243580

  • 1. Erythropoietin as an antiapoptotic, tissue-protective cytokine.
    Ghezzi P, Brines M.
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S37-44. PubMed ID: 15243580
    [Abstract] [Full Text] [Related]

  • 2. A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent.
    Savino R, Ciliberto G.
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S2-4. PubMed ID: 15243576
    [No Abstract] [Full Text] [Related]

  • 3. Erythropoietin and the hypoxic brain.
    Marti HH.
    J Exp Biol; 2004 Aug; 207(Pt 18):3233-42. PubMed ID: 15299044
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythropoietin as a neuroprotective agent in traumatic brain injury Review.
    Mammis A, McIntosh TK, Maniker AH.
    Surg Neurol; 2009 May; 71(5):527-31; discussion 531. PubMed ID: 18789503
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X.
    Neurosci Lett; 2007 Oct 02; 425(3):177-82. PubMed ID: 17825990
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
    Jelkmann W, Wagner K.
    Ann Hematol; 2004 Nov 02; 83(11):673-86. PubMed ID: 15322761
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin as a novel neuroprotectant.
    Genc S, Koroglu TF, Genc K.
    Restor Neurol Neurosci; 2004 Nov 02; 22(2):105-19. PubMed ID: 15272145
    [Abstract] [Full Text] [Related]

  • 10. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
    Liu R, Suzuki A, Guo Z, Mizuno Y, Urabe T.
    J Neurochem; 2006 Feb 02; 96(4):1101-10. PubMed ID: 16417583
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.
    van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F.
    Brain Res Rev; 2008 Nov 02; 59(1):22-33. PubMed ID: 18514916
    [Abstract] [Full Text] [Related]

  • 14. TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells.
    Pregi N, Wenker S, Vittori D, Leirós CP, Nesse A.
    Exp Cell Res; 2009 Feb 01; 315(3):419-31. PubMed ID: 19056379
    [Abstract] [Full Text] [Related]

  • 15. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A, Baskin H, Yesilirmak DC, Ergur BU, Aykan S, Genc S, Genc K, Yilmaz O, Tugyan K, Giray O, Duman N, Ozkan H.
    Neonatology; 2007 Feb 01; 92(4):269-78. PubMed ID: 17627093
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
    Yoshimi M, Maeyama T, Yamada M, Hamada N, Fukumoto J, Kawaguchi T, Kuwano K, Nakanishi Y.
    Respirology; 2008 Sep 01; 13(5):639-45. PubMed ID: 18713087
    [Abstract] [Full Text] [Related]

  • 17. Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model.
    Kitamura H, Isaka Y, Takabatake Y, Imamura R, Suzuki C, Takahara S, Imai E.
    Nephrol Dial Transplant; 2008 May 01; 23(5):1521-8. PubMed ID: 18194980
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietin does not attenuate cytokine production and inflammation in microglia--implications for the neuroprotective effect of erythropoietin in neurological diseases.
    Wilms H, Schwabedissen B, Sievers J, Lucius R.
    J Neuroimmunol; 2009 Jul 25; 212(1-2):106-11. PubMed ID: 19464738
    [Abstract] [Full Text] [Related]

  • 19. Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders.
    Diaz Z, Assaraf MI, Miller WH, Schipper HM.
    J Neurochem; 2005 Apr 25; 93(2):392-402. PubMed ID: 15816862
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.
    Okutan O, Solaroglu I, Beskonakli E, Taskin Y.
    J Clin Neurosci; 2007 Apr 25; 14(4):364-8. PubMed ID: 17236773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.